Rankings
▼
Calendar
VCEL Q3 2017 Earnings — Vericel Corporation Revenue & Financial Results | Market Cap Arena
VCEL
Vericel Corporation
$2B
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$14M
+30.5% YoY
Gross Profit
$7M
49.6% margin
Operating Income
-$4M
-28.3% margin
Net Income
-$5M
-37.9% margin
EPS (Diluted)
$-0.16
QoQ Revenue Growth
-15.9%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$6M
Stock-Based Comp.
$755,000
Balance Sheet
Total Assets
$40M
Total Liabilities
$24M
Stockholders' Equity
$17M
Cash & Equivalents
$15M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$14M
$11M
+30.5%
Gross Profit
$7M
$4M
+73.7%
Operating Income
-$4M
-$6M
+36.8%
Net Income
-$5M
-$7M
+19.0%
← FY 2017
All Quarters
Q4 2017 →